|
XPO4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.7830999999322E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.200020E-04 |
| Normal-vs-Stage2 |
5.984200E-02 |
| Normal-vs-Stage3 |
1.02490005371436E-09 |
| Normal-vs-Stage4 |
8.28130009011829E-10 |
| Stage1-vs-Stage2 |
6.671600E-01 |
| Stage1-vs-Stage3 |
5.199600E-04 |
| Stage1-vs-Stage4 |
3.991700E-04 |
| Stage2-vs-Stage3 |
3.131800E-02 |
| Stage2-vs-Stage4 |
1.790420E-02 |
| Stage3-vs-Stage4 |
6.455200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.14070000018552E-07 |
| Normal-vs-AfricanAmerican |
1.57430000036207E-07 |
| Normal-vs-Asian |
6.582200E-01 |
| Caucasian-vs-AfricanAmerican |
1.508190E-01 |
| Caucasian-vs-Asian |
1.893350E-01 |
| AfricanAmerican-vs-Asian |
4.455800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.69039999565035E-08 |
| Normal-vs-Female |
4.0956000000314E-06 |
| Male-vs-Female |
4.795200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.641410E-04 |
| Normal-vs-Age(41-60Yrs) |
1.75101999999594E-05 |
| Normal-vs-Age(61-80Yrs) |
6.16190000135575E-08 |
| Normal-vs-Age(81-100Yrs) |
1.377800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.692600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.454600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.484400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.233800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.375600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.060400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.532580E-01 |
| Normal-vs-Grade 2 |
1.773930E-04 |
| Normal-vs-Grade 3 |
4.68790000152097E-08 |
| Normal-vs-Grade 4 |
5.90599791294721E-11 |
| Grade 1-vs-Grade 2 |
6.744400E-01 |
| Grade 1-vs-Grade 3 |
1.891650E-01 |
| Grade 1-vs-Grade 4 |
1.275960E-02 |
| Grade 2-vs-Grade 3 |
3.045800E-02 |
| Grade 2-vs-Grade 4 |
1.779800E-04 |
| Grade 3-vs-Grade 4 |
1.120430E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.720900E-03 |
| Normal-vs-ccB subtype |
4.19439999954641E-07 |
| ccA subtype-vs-ccB subtype |
5.520600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.50790000000389E-06 |
| Normal-vs-N1 |
3.060200E-02 |
| N0-vs-N1 |
5.981000E-01 |
|
|
